Information:
Error:
ID
22349
Description
Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00253084
Link
https://clinicaltrials.gov/show/NCT00253084
Keywords
Versions (1)
- 5/31/17 5/31/17 -
Uploaded on
May 31, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Parkinson's Disease NCT00253084
Eligibility Parkinson's Disease NCT00253084
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT00253084
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Parkinson Disease
Item
diagnosed with idiopathic parkinson's disease based on capit (core assessment program for intracerebral transplantations) criteria.
boolean
C0030567 (UMLS CUI [1])
Carbidopa / Levodopa Dose Stable
Item
currently being treated with immediate-release carbidopa-levodopa with a stable dosing regimen over the past 4 weeks.
boolean
C0353697 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0677946 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0677946 (UMLS CUI [1,3])
Atypical Parkinson Disease
Item
diagnosed with atypical parkinsonism.
boolean
C1868596 (UMLS CUI [1])
Carbidopa + levodopa allergy | Carbidopa / Levodopa | Unresponsive to Treatment
Item
allergic or non-responsive to previous carbidopa-levodopa therapy.
boolean
C0570732 (UMLS CUI [1])
C0353697 (UMLS CUI [2])
C0205269 (UMLS CUI [3])
C0353697 (UMLS CUI [2])
C0205269 (UMLS CUI [3])
Angle Closure Glaucoma | Glaucoma, Open-Angle
Item
active or history of narrow-angle or wide-angle glaucoma.
boolean
C0017605 (UMLS CUI [1])
C0017612 (UMLS CUI [2])
C0017612 (UMLS CUI [2])
Seizures | Epilepsy | Anticonvulsants
Item
history of seizure or epilepsy, or is currently taking an anti-convulsant for treatment of seizure.
boolean
C0036572 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
C0014544 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
Tricyclic Antidepressive Agents | MAO-B Inhibitors | Catechol-O-methyltransferase inhibitor | Anticholinergic Agents
Item
requires concomitant therapy with tricyclic antidepressants, mao-b inhibitors, comt inhibitors or anticholinergics.
boolean
C0003290 (UMLS CUI [1])
C4020574 (UMLS CUI [2])
C0595267 (UMLS CUI [3])
C0242896 (UMLS CUI [4])
C4020574 (UMLS CUI [2])
C0595267 (UMLS CUI [3])
C0242896 (UMLS CUI [4])
Antipsychotic Agents | Antipsychotic Agents Atypical
Item
treatment with any neuroleptic agent, including atypical neuroleptics, within the previous 6 months.
boolean
C0040615 (UMLS CUI [1])
C0040615 (UMLS CUI [2,1])
C0205182 (UMLS CUI [2,2])
C0040615 (UMLS CUI [2,1])
C0205182 (UMLS CUI [2,2])
Dopamine Antagonists
Item
treatment with any dopaminergic blocking agent within the previous 6 months.
boolean
C0242702 (UMLS CUI [1])